BioBeats, a London, UK-based a digital health and artificial intelligence company, closed a £2.4M funding round.
The round was led by Oxford Sciences Innovation (OSI), White Cloud and IQ Capital.
The company intends to use the funds to deliver its wellness solutions to a global audience.
Led by Iain Martin, CEO, David Plans, CSO, and Davide Morelli, CTO, BioBeats specializes in creating corporate and personal wellness solutions providing insights into individual health and wellbeing by tracking data from wearable and smartphone sensors. Biometric and psychometric feedback is combined with machine learning algorithms to deliver personalized stress and productivity management tools based on clinically proven coaching techniques.
Its app, BioBase, offers users the ability to track, manage and control stress.